Submission Details
| 510(k) Number | K051824 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 05, 2005 |
| Decision Date | August 18, 2005 |
| Days to Decision | 44 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K051824 is an FDA 510(k) clearance for the INVADER UGT1A1 MOLECULAR ASSAY, a Drug Metabolizing Enzyme Genotyping Systems (Class II — Special Controls, product code NTI), submitted by Third Wave Technologies, Inc. (Madison, US). The FDA issued a Cleared decision on August 18, 2005, 44 days after receiving the submission on July 5, 2005. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3360.
| 510(k) Number | K051824 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 05, 2005 |
| Decision Date | August 18, 2005 |
| Days to Decision | 44 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NTI — Drug Metabolizing Enzyme Genotyping Systems |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3360 |
| Definition | Intended To Identify The Presence Or Absence Of Human Genotypic Markers Encoding Drug Metaboizing Enzymes Using Dna Originating From Clinical Samples. This Type Of Assay Can Be Used As An Aid Determining Treatment Choice And Individualizing Treatment Dose For Therapeutics That Are Metabolized Primarily By The Specific Enzyme Tested By The System. |